作者: David Edward Gilham , John Anderson , John Stephen Bridgeman , Robert Edward Hawkins , Mark Adrian Exley
DOI: 10.1089/HUM.2015.024
关键词:
摘要: Adoptive T-cell therapy is delivering objective clinical responses across a number of cancer indications in the early phase setting. Much this activity taking place at major academic centers United States. This review focuses upon cancer-focused cell within Kingdom as contribution to 2015 British Society Gene and Cell Therapy annual general meeting. overview reflects diversity expansion preclinical studies while considering background context work against new infrastructural developments requirements nationalized healthcare delivery UK National Health Service.